Related Experiment Videos
A convenient method for the identification and expression of eukaryotic genes
Rongliang Hu1, Shoufeng Zhang, Qing Xu
1Laboratory of Genetic Engineering, Veterinary Institute, Academy of Military Science, 175 Xi An Road, Changchun 130062, People's Republic of China. hurongliang@hotmail.com
Biotechnology and Applied Biochemistry
|May 25, 2004
Summary
Researchers developed an efficient in vivo system for producing biological proteins in goat mammary glands. This method allows for high-level expression of therapeutic proteins like lumbrokinase and tissue-type plasminogen activator.
Area of Science:
- Biotechnology
- Molecular Biology
- Biochemistry
Background:
- Traditional methods for assessing eukaryotic gene product activity involve in vitro systems.
- Mammalian expression vectors are commonly used for gene expression studies.
- An efficient in vivo system offers advantages for protein production and biological activity assessment.
Purpose of the Study:
- To develop an efficient in vivo system for expressing eukaryotic genes in lactating-goat mammary glands.
- To assess the biological activity of expressed proteins using a mammary-gland-specific vector.
- To evaluate the potential of this system as a bioreactor for biological protein production.
Main Methods:
- Synthesized lumbrokinase cDNA variant (LK-m) and tissue-type plasminogen activator (tPA) cDNA were cloned downstream of the goat beta-casein regulatory sequence.
- Expression plasmids were injected into lactating-goat mammary gland tissues.
- Fibrin-agarose plate assay was used to detect fibrin-lysis activity, indicating protein expression.
Main Results:
- High-level expression of LK-m and tPA was detected, demonstrating significant fibrin-lysis activity.
- Specific expression initiated immediately post-injection, peaking within 6-9 hours.
- Peak expression persisted for 20-24 hours and lasted for 4 days with a gradual decline.
Conclusions:
- An efficient in vivo expression system was successfully developed in lactating-goat mammary glands.
- This system enables high-level production and functional assessment of therapeutic proteins.
- The developed system shows potential as a bioreactor for producing biological proteins, offering an alternative to transgenic animals.